These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 15265864)

  • 1. Factor IX mutants with enhanced catalytic activity.
    Hartmann R; Dockal M; Kammlander W; Panholzer E; Nicolaes GA; Fiedler C; Rosing J; Scheiflinger F
    J Thromb Haemost; 2009 Oct; 7(10):1656-62. PubMed ID: 19656280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding studies of the enzyme (factor IXa) with the cofactor (factor VIIIa) in the assembly of factor-X activating complex on the activated platelet surface.
    Ahmad SS; London FS; Walsh PN
    J Thromb Haemost; 2003 Nov; 1(11):2348-55. PubMed ID: 14629468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice.
    Østergaard H; Lund J; Greisen PJ; Kjellev S; Henriksen A; Lorenzen N; Johansson E; Røder G; Rasch MG; Johnsen LB; Egebjerg T; Lund S; Rahbek-Nielsen H; Gandhi PS; Lamberth K; Loftager M; Andersen LM; Bonde AC; Stavenuiter F; Madsen DE; Li X; Holm TL; Ley CD; Thygesen P; Zhu H; Zhou R; Thorn K; Yang Z; Hermit MB; Bjelke JR; Hansen BG; Hilden I
    Blood; 2021 Oct; 138(14):1258-1268. PubMed ID: 34077951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular models of the procoagulant factor VIIIa-factor IXa complex.
    Autin L; Miteva MA; Lee WH; Mertens K; Radtke KP; Villoutreix BO
    J Thromb Haemost; 2005 Sep; 3(9):2044-56. PubMed ID: 16102111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing activation-driven changes in coagulation factor IX by mass spectrometry.
    Freato N; van Alphen FPJ; Boon-Spijker M; van den Biggelaar M; Meijer AB; Mertens K; Ebberink EHTM
    J Thromb Haemost; 2021 Jun; 19(6):1447-1459. PubMed ID: 33687765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and regulation of coagulation factor X activation by intrinsic tenase on phospholipid membranes.
    Sveshnikova AN; Shibeko AM; Kovalenko TA; Panteleev MA
    J Theor Biol; 2024 Apr; 582():111757. PubMed ID: 38336240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is all that thrombin for?
    Mann KG; Brummel K; Butenas S
    J Thromb Haemost; 2003 Jul; 1(7):1504-14. PubMed ID: 12871286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies.
    Luan D; Zai M; Varner JD
    PLoS Comput Biol; 2007 Jul; 3(7):e142. PubMed ID: 17658944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor IXa variants resistant to plasma inhibitors enhance clot formation in vivo.
    Ivanciu L; Arruda VR; Camire RM
    Blood; 2023 Apr; 141(16):2022-2032. PubMed ID: 36724452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustered basic residues within segment 484-510 of the factor VIIIa A2 subunit contribute to the catalytic efficiency for factor Xa generation.
    Jenkins PV; Dill JL; Zhou Q; Fay PJ
    J Thromb Haemost; 2004 Mar; 2(3):452-8. PubMed ID: 15009463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood coagulation factor IX: structural insights impacting hemophilia B therapy.
    Bos MHA; van Diest RE; Monroe DM
    Blood; 2024 Jul; ():. PubMed ID: 38996207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel factor IXa-specific enzyme-linked immunosorbent assay detects factor IXa in human plasma.
    Misenheimer TM; Lasarev MR; Kumfer KT; Sheehan JP; Schwartz BS
    Res Pract Thromb Haemost; 2024 Jan; 8(1):102338. PubMed ID: 38433974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycosylation prolongs the circulation of coagulation factor IX.
    Bolt G; Bjelke JR; Hermit MB; Hansen L; Karpf DM; Kristensen C
    J Thromb Haemost; 2012 Nov; 10(11):2397-8. PubMed ID: 22938555
    [No Abstract]   [Full Text] [Related]  

  • 14. Mapping the zymogen to protease transition in FIXa.
    Sheehan JP
    J Thromb Haemost; 2021 Jun; 19(6):1409-1411. PubMed ID: 34047009
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor X inhibitors: A seldom seen but important antibody mediated process.
    Gollard R
    Haemophilia; 2023 Sep; 29(5):1175. PubMed ID: 37647206
    [No Abstract]   [Full Text] [Related]  

  • 16. A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model.
    Kitazawa T; Igawa T; Sampei Z; Muto A; Kojima T; Soeda T; Yoshihashi K; Okuyama-Nishida Y; Saito H; Tsunoda H; Suzuki T; Adachi H; Miyazaki T; Ishii S; Kamata-Sakurai M; Iida T; Harada A; Esaki K; Funaki M; Moriyama C; Tanaka E; Kikuchi Y; Wakabayashi T; Wada M; Goto M; Toyoda T; Ueyama A; Suzuki S; Haraya K; Tachibana T; Kawabe Y; Shima M; Yoshioka A; Hattori K
    Nat Med; 2012 Oct; 18(10):1570-4. PubMed ID: 23023498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies.
    Dutta K; Varshney AK; Franklin MC; Goger M; Wang X; Fries BC
    J Biol Chem; 2015 Mar; 290(11):6715-30. PubMed ID: 25572397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-induced enhancement of factor VIIa activity through distinct allosteric pathways.
    Andersen LM; Andreasen PA; Svendsen I; Keemink J; Østergaard H; Persson E
    J Biol Chem; 2012 Mar; 287(12):8994-9001. PubMed ID: 22275370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antibody specific for coagulation factor IX enhances the activity of the intrinsic factor X-activating complex.
    Kerschbaumer RJ; Riedrich K; Kral M; Varadi K; Dorner F; Rosing J; Scheiflinger F
    J Biol Chem; 2004 Sep; 279(39):40445-50. PubMed ID: 15265864
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.